More NewsRead More
Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call
February 18, 2015
Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R)
February 11, 2015
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2015 Leerink Global Healthcare Conference
February 05, 2015
AMITIZA(R) (lubiprostone) Mutual Recognition Procedure Closes With Recommendation for Approval in European Countries
January 30, 2015
Robert J. Spiegel, M.D., FACP Joins Sucampo's Board of Directors
January 21, 2015
Daily Pharma Dose: New Research on Hospira, Aquinox, Sucampo, NephroGenex and OncoGenex
December 31, 2014
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here